Showing results (581-590 of 904) with videos related to

Sort By:
Pageof 91
Microcirculation (New York, N.Y. : 1994)|May 9, 2019
Early retinal microvascular abnormalities in patients with chronic kidney diseaseLing Yeung, I-Wen Wu, Chi-Chin Sun, et al.
Free Radical Biology & Medicine|May 15, 2009
Pretreatment with interferon-gamma protects microglia from oxidative stress via up-regulation of Mn-SODXia Chen, In Young Choi, Tong-Shin Chang, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|August 4, 2021
Comprehensive Clinicopathologic Analysis for Mismatch Repair Protein Expression in Unselected Endometrial Carcinoma Patients With an Emphasis on the Role of MLH1 DeficiencySzu-Wei Huang, Hao Lin, Chao-Cheng Huang, et al.
Frontiers in Pharmacology|January 10, 2017
Antinociceptive Effects of AGAP, a Recombinant Neurotoxic Polypeptide: Possible Involvement of the Tetrodotoxin-Resistant Sodium Channels in Small Dorsal Root Ganglia NeuronsChun-Li Li, Xi-Fang Liu, Gui-Xia Li, et al.
International Immunopharmacology|June 14, 2008
RV09, a novel resveratrol analogue, inhibits NO and TNF-alpha production by LPS-activated microgliaXue Lian Meng, Jing Yu Yang, Guo Liang Chen, et al.
The Journal of Biological Chemistry|April 29, 2005
A novel 43-kDa protein as a negative regulatory component of phenoloxidase-induced melanin synthesisMingyi Zhao, Irene Söderhäll, Ji Won Park, et al.
American Journal of Cancer Research|September 15, 2025
Enhanced prognostic stratification in early-stage epithelial ovarian cancer: multi-histological analysis of neutrophil-to-lymphocyte ratio with particular emphasis on clear cell histologyEn-Ling Sung, Hao Lin, Yu-Che Ou, et al.
Taiwanese Journal of Obstetrics & Gynecology|June 26, 2026
Evaluating homologous recombination status and the efficacy/safety of PARP inhibitors in advanced epithelial ovarianl cancer: A single-institute preliminary experienceChen-Hsuan Wu, Yu-Che Ou, Hung-Chun Fu, et al.
Mechanisms of Ageing and Development|July 23, 2015
A novel phosphodiesterase-5 Inhibitor: Yonkenafil modulates neurogenesis, gliosis to improve cognitive function and ameliorates amyloid burden in an APP/PS1 transgenic mice modelLei Zhu, Jing-yu Yang, Xue Xue, et al.
European Journal of Pharmacology|September 25, 2016
SYP-5, a novel HIF-1 inhibitor, suppresses tumor cells invasion and angiogenesisLi-Hui Wang, Xiao-Rui Jiang, Jing-Yu Yang, et al.
Pageof 91